FDA Approves Alunbrig for ALK+ NSCLC Treatment
- Brigatinib. U.S Food and Drug Administration - Approved Drugs. Accessed at: https://www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm555841.htm
- Takeda Announces FDA Accelerated Approval of ALUNBRIGTM (brigatinib). April 28, 2017. Takeda - News Release. Accessed at: https://www.takeda.com/newsroom/newsreleases/2017/alunbrig-fda-approval/
- My Cancer Genome. Accessed online on 8/14/16 at https://www.mycancergenome.org/.
- Genetics Home Reference, National Institutes of Health. Accessed online on 8/2/16 at https://ghr.nlm.nih.gov/.